Title
Sentinel Node Biopsy Imaging in Breast Cancer Scatter Reduction Using 3-Dimensionally Printed Lead ShieldsAuthor
Author (from another institution)
xmlui.dri2xhtml.METS-1.0.item-contributorOtherinstitution
https://ror.org/040xzg562VietTin Land Investment and Consultant
https://ror.org/03taz7m60
https://ror.org/02zt1gg83
https://ror.org/01cmnjq37
Version
http://purl.org/coar/version/c_970fb48d4fbd8a85
Rights
© 2022 The AuthorsAccess
http://purl.org/coar/access_right/c_abf2Publisher’s version
https://doi.org/10.1097/RLU.0000000000004274Published at
Clinical Nuclear Medicine Vol. 47. N. 7. P.p. 618-624,xmlui.dri2xhtml.METS-1.0.item-publicationfirstpage
618xmlui.dri2xhtml.METS-1.0.item-publicationlastpage
624Publisher
Wolters KluwerKeywords
Breast cancer
lead shield
lymphoscintigraphy
scatter ... [+]
lead shield
lymphoscintigraphy
scatter ... [+]
Breast cancer
lead shield
lymphoscintigraphy
scatter
sentinel lymph node
sentinel node biopsy [-]
lead shield
lymphoscintigraphy
scatter
sentinel lymph node
sentinel node biopsy [-]
Abstract
Background
Point of injection scatter (SPI) confounds breast cancer sentinel lymph node detection. Round flat lead shields (FLSs) incompletely reduce SPI, requiring repositioning. We designed lead s ... [+]
Background
Point of injection scatter (SPI) confounds breast cancer sentinel lymph node detection. Round flat lead shields (FLSs) incompletely reduce SPI, requiring repositioning. We designed lead shields that reduce SPI and acquisition time.
Methods
Two concave lead shields, a semioval lead shield (OLS) and a semispherical lead alloy shield (SLS), were created with a SICNOVA JCR 1000 3D printer to cover the point of injection (patent no. ES1219895U). Twenty breast cancer patients had anterior and anterior oblique imaging, 5 minutes and 2 hours after a single 111 MBq nanocolloid in 0.2 mL intratumoral or periareolar injection. Each acquisition was 2 minutes. Absolute and normalized background corrected scatter counts (CSCs) and scatter reduction percentage (%SR) related to the FLS were calculated. Repositionings were recorded. Differences between means of %SR (t test) and between means of CSC (analysis of variance) with Holm multiple comparison tests were determined.
Results
Mean %SR was 91.8% with OLS and 92% using SLS in early images (P = 0.91) and 87.2%SR in OLS and 88.5% in late images (P = 0.66). There were significant differences between CSC using FLS and OLS (P < 0.001) and between FLS and SLS (P < 0.001), but not between OLS and SLS (P = 0.17) in early images, with the same results observed in delayed studies (P < 0.001 in relation to FLS and P = 0.1 between both curved lead shields). Repositioning was required 14/20 times with FLS, 4/20 times with OLS, and 2/20 times with SLS.
Conclusions
We designed 2 concave lead shields that significantly reduce the SPI and repositioning with sentinel lymph node lymphoscintigraphy. [-]
Collections
- Articles - Engineering [684]
The following license files are associated with this item: